Diabetes is a rising epidemic in the United States, with 25.8 million Americans dealing with the chronic illness on a day-to-day basis. With that, many medical device companies are developing new and better ways to help manage diabetes, especially for our “on-the-go” fast paced society. That’s where we come in.
Advanced Instruments Technologies Inc.—an NI Alliance Partner— and Test Systems Pro Inc. used NI LabVIEW software, the NI Spectral Measurements Toolkit, NI TestStand, and NI PXI RF hardware to develop RF and production tests for the subcomponents of an FDA Class II medical glucose meter and insulin delivery system. This system uses RF technology to wirelessly communicate the blood glucose readings of the patient to an insulin delivery actuator that will pump insulin as necessary.
When developing the tests, engineers considered traditional boxed instruments, but they chose the NI PXI-5661 vector signal analyzer and the NI PXIe-5672 vector signal generator because of the ability to smoothly integrate these devices with LabVIEW. These NI products were also cheaper, more compact, and made integration into the test system easier and more efficient. Matthew Kelton of AIT said he knew that NI products would be the best choice because “the NI VSA/VSG solution [is] significantly faster than the boxed instrument equivalent – testing would have taken several minutes longer if traditional boxed instruments were used."
With this technology, we are one step closer to finding a cure for diabetes. The ability for a glucose meter to wirelessly communicate to an insulin delivery device opens the door for diabetics to have better control and fewer complications.